Stellula Therapeutics

Stellula Therapeutics is a biotechnology company developing next-generation gene therapies for rare and devastating neurological disorders. The company is focused on a gene therapy for SCN8A developmental and epileptic encephalopathy, a rare pediatric genetic epilepsy disorder, originating from research at the University of Virginia.